Tangier disease or Hypoalphalipoproteinemia is a genetic disorder characterized by an extreme reduction in the quantity of high density lipoprotein or good cholesterol in the bloodstream. People with Tangier disease frequently have orange or yellow tonsils, scar-like tissue lining the arteries, an enlarged spleen and liver, and clouding of the cornea. Only 100 cases world wide of Tangier disease has been recorded. There is no treatment as of now for Tangier disease, medicines that have proven to raise HDL levels have not worked on patients with Tangier disease.
Tangier Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Tangier Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 370 products for the study of Tangier Disease that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Tangier Disease is also known as tangier disease, familial high density lipoprotein deficiency disease, familial hypoalphalipoproteinemia, familial hdl deficiency, carbamoyl-phosphate synthase i deficiency disease, high density lipoprotein deficiency, tangier type, lipoprotein deficiency disease, hdl, familial, familial high density lipoprotein deficiency, high density lipoprotein deficiency, type 1, familial alpha-lipoprotein deficiency, hypoalphalipoproteinemia, familial, familial lipoprotein deficiency, analphalipo-proteinemia, analphalipoproteinemia, hdldt1.